Astellas Pharma Inc (OTC Pink - Current Information:ALPMF.PK)

16.17
Delayed Data
As of Jun 15
 0.00 / 0.00%
Today’s Change
11.89
Today|||52-Week Range
16.17
--
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$31.3B

Company Description

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Contact Information

Astellas Pharma, Inc.
2-5-1 Nihonbashi-Honcho
Tokyo Tokyo 103-8411
P:(133) 244-3000
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Kenji YasukawaPresident, CEO & Representative Director
Chikashi TakedaChief Financial Officer
Akira KamimuraManager-Accounting & IR Contact
Mitsunori MatsudaGeneral Manager-Pharmaceutical Technology
Fumiaki SakuraiExecutive Officer & Head-Compliance